DRMA
Dermata Therapeutics·NASDAQ
--
--(--)
--
--(--)
DRMA Filings
Filing Date
Form Description
Form Type
2026-02-03
Form 8-K - Current report
Key Events
2026-02-03 · Key Events
Form 8-K - Current report
2026-02-02
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-02-02 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-30
Form EFFECT - Notice of Effectiveness
2026-01-30 ·
Form EFFECT - Notice of Effectiveness
2026-01-29
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-29 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27
Form 8-K - Current report
Key Events
2026-01-27 · Key Events
Form 8-K - Current report
2026-01-27
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-27 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-01-22
Form S-3 - Registration statement under Securities Act of 1933
2026-01-22 ·
Form S-3 - Registration statement under Securities Act of 1933
2026-01-08
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-08 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-07
Form D - Notice of Exempt Offering of Securities
2026-01-07 ·
Form D - Notice of Exempt Offering of Securities
2026-01-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
